PlainRecalls
FDA Drug Moderate Class II Terminated

Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Reported: October 13, 2021 Initiated: October 4, 2021 #D-0004-2022

Product Description

Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Reason for Recall

Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

Details

Recalling Firm
Akorn, Inc.
Units Affected
10,210 bottles
Distribution
Distributed Nationwide in the USA
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11. Recalled by Akorn, Inc.. Units affected: 10,210 bottles.
Why was this product recalled?
Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 13, 2021. Severity: Moderate. Recall number: D-0004-2022.